Advocacy Campaigns

The California State Assembly’s Committee on Commuter Rail Safety invited Paul Hedlund, attorney and mechanical engineer, to testify about how to improve passenger train safety in the wake of the January 2005 Metrolink derailment in Southern California. Mr. Hedlund played two test crash films created by the federal government in order to show improved crashworthiness for passenger cars. He also discussed push vs pull. “Pulling trains with locomotives is not a magic bullet. . . but it is hard to imagine that there would have been any deaths and injuries on Jan. 26 had the train been pulled,” The Los Angeles Times quoted Paul Hedlund.

Several Wisner Baum staff and clients attended three different antidepressant safety hearings held by the Food and Drug Administration (FDA). Wisner Baum and several clients testified at each hearing about the risk of suicide in children and adults taking SSRI-antidepressants. Two hearings were held in 2004 by the FDA’s Psychopharmacologic Drugs and Pediatric Advisory Committees about the risk of suicide in children and adolescents taking antidepressants. After examining data from the clinical trials of antidepressants, the FDA concluded that the risk does, indeed, exist. Shortly thereafter, the FDA ordered manufacturers of more than thirty antidepressants to include a black box warning (the most severe warning) on their label stating that the drugs increase the risk of suicidal behavior in children and adolescents. The FDA also required that Patient Medication Guides be distributed to patients prescribed the drugs. Our firm and our clients testified a third time, in 2006, before the FDA’s Psychopharmacologic Drugs Advisory Committee about the risk of suicide in adults. Testimony and evidence presented at this hearing resulted in the expansion of the black box warnings to young adults. We are doing what we can to ensure the suicide warning applies to everyone, regardless of age.

Taiwan’s Ministry of Health urged Michael Baum to present evidence of fraud to their hemophilia community. After reading a quote by Michael Baum in the New York Times, Taiwan’s Ministry of Health invited him to their country for an urgent meeting. Officials wanted to see Wisner Baum’s smoking gun documents showing that the U.S. manufacturers of hemophilia medication were, in fact, committing a fraud on Taiwan by knowingly urging doctors to prescribe HIV contaminated medication to their hemophilia community.

Wisner Baum accepted an invitation from Senator Tom Torlakson to testify at the joint informational hearing of the California State Senate Health and Human Services Committee and the Statewide Task Force on Youth about suicide and antidepressant medications. Senator Torlakson’s niece committed suicide after taking an antidepressant. The purpose of the hearing was to review the possible connection between suicide and antidepressant drugs.

Wisner Baum assisted Congressional Investigators from two separate Committee investigations looking into the safety of antidepressants. Two Congressional hearings were later held at which pharmaceutical executives and FDA officials were interrogated about their failure to protect the public health related to antidepressants and their association with suicidality.

Other continuing safety efforts have included arranging for one of our clients and Paul Hedlund to testify before the California State Legislature regarding seismic safety after the death of our client’s son due to the collapse of a building known to be vulnerable to tremors during an earthquake.